Publication | Closed Access

A Formulation Development Approach to Identify and Select Stable Ultra–High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities

Formulation Development ApproachReduced ViscositiesImmunologyPharmaceutical TechnologyDrug Delivery SystemsImmunochemistryAntibody EngineeringImmunotherapeuticsBiomedical EngineeringAntibody ScreeningMedicine